
Ojal Pharmaceuticals Private Limited
Wholesale trading of pharmaceutical products, incorporated in 2019 in Madhya Pradesh.
Wholesale trading of pharmaceutical products, incorporated in 2019 in Madhya Pradesh.
Ojal Pharmaceuticals Private Limited (OPPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 January 2019 (Six years and three months 15 days old ). Its registered office is in Indore, Madhya Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 5.86 M, as per Ministry of Corporate Affairs (MCA) records.
Giriraj Gupta, Anil Chopra, Kirti Shah, and One other member serve as directors at the Company.
Indore, Madhya Pradesh, India
+91-XXXXXXXXXX
U24290MP2019PTC047557
047557
Private Limited Indian Non-Government Company
18 Jan 2019
30 Sep 2024
31 Mar 2024
Unlisted
Roc Gwalior
Ojal Pharmaceuticals Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antiviral Drugs.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Giriraj Gupta ![]() | Director | 18-Jan-2019 | Current |
Anil Chopra ![]() | Director | 27-Dec-2019 | Current |
Kirti Shah | Additional Director | 26-Jul-2024 | Current |
Surbhi Gupta | Additional Director | 26-Jul-2024 | Current |
Ojal Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 57.17% increase. The company also saw a substantial improvement in profitability, with a 163.46% increase in profit. The company's net worth Soared by an impressive increase of 123.29%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2021, Ojal Pharmaceuticals had a public holding of 11.21%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Ojal Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ojal Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ojal Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ojal Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Kirti Shah was appointed as a Additional Director was appointed as a Additional Director on 26 Jul 2024 & has been associated with this company since 9 months 7 days .
Surbhi Gupta was appointed as a Additional Director was appointed as a Additional Director on 26 Jul 2024 & has been associated with this company since 9 months 7 days .
Ojal Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior.
Anil Kumar Chopra was appointed as a Director was appointed as a Director on 27 Dec 2019 & has been associated with this company since 5 years 4 months .
Giriraj Gupta was appointed as a Director was appointed as a Director on 18 Jan 2019 & has been associated with this company since 6 years 3 months .
Ojal Pharmaceuticals Private Limited was incorporated on 18 Jan 2019.
The authorized share capital of Ojal Pharmaceuticals Private Limited is ₹ 1.00 Cr and paid-up capital is ₹ 5.86 M.
Currently 4 directors are associated with Ojal Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Ojal Pharmaceuticals Private Limited is Ch-11 Kadambri Housing Board Colony Silicon City, Rau Road India, Indore, Madhya Pradesh, 452012.
The corporate identification number (CIN) of Ojal Pharmaceuticals Private Limited is U24290MP2019PTC047557 and the company number is 047557 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2021, the revenue trend for Ojal Pharmaceuticals Private Limited has risen by 57.17%.
The financial reports for the fiscal year 2021 indicates that The net worth of Ojal Pharmaceuticals Private Limited has experienced an upsurge of 123.29%.
The most recent Balance Sheet for Ojal Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
AB